Financhill
Back

United Therapeutics 10K Form

Buy
62

UTHR
United Therapeutics

Last Price:
$315.44
Seasonality Move:
9.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive UTHR News And Ratings

See the #1 stock for the next 7 days that we like better than UTHR

UTHR Financial Statistics

Sales & Book Value

Annual Sales: $2.9B
Cash Flow: $386.3M
Price / Cash Flow: 13.46
Annual Sales: $151.02
Price / Book: 2.09

Profitability

EPS (TTM): 25.06000
Net Income (TTM): $1.2B
Gross Margin: $2.6B
Return on Equity: 19.92%
Return on Assets: 17.08%

United Therapeutics Earnings Forecast

Key United Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 26 years for UTHR is 89.24%.
  • The Selling, General & Administrative Expenses for UTHR have been equal to 22.19% of Gross Profit Margin.
  • The Research & Development expenses have been 16.72% of Revenue.
  • The Interest Expense is 3.59% of Operating Income.
  • The Net Earning history of UTHR is 41.53% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 18 years.

United Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UTHR
CUSIP: 91307C
Website: unither.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 5.46
Quick Ratio: 5.05

Price-to-Earnings

Trailing P/E Ratio: 12.78
Forward P/E Ratio: 10.49

UTHR Technical Analysis vs Fundamental Analysis

Buy
62
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?